Microsoft co-founder Bill Gates is fascinating. So is the 19-page annual letter that describes the work of the Bill and Melinda Gates Foundation, the world’s largest philanthropic organization. But for someone as smart as Gates, who can afford to hire experts on any subject under the sun, some of his foundation’s strategies are baffling.
Consider his foundation’s approach to malaria, which focuses on bed nets, a low-tech, only modestly effective intervention, and on the development of a vaccine, a high-tech solution that has eluded intensive efforts for decades. This approach dismisses an old, cheap and safe way to control the vector — the Anopheles mosquito — that spreads the disease: the chemical DDT.
Malaria is a scourge, particularly for inhabitants of poor tropical countries. 41 percent of the world’s population live in areas where malaria is transmitted, with 350 million to 500 million cases each year.
The disease imposes substantial costs on individuals, families and governments. Costs to individuals and their families include drugs, travel to and treatment at clinics, lost time at work and school and expenses for preventive measures. Costs to governments include maintenance of health facilities, purchases of drugs and supplies, public-health interventions such as spraying insecticide or distributing insecticide-treated bed nets and lost revenue from taxes and tourism.
Such costs are a huge economic burden on malaria-prone countries and impede their development. It has been estimated that annual economic growth in countries with a high incidence of malaria is 1.3 percentage points lower than that of other countries.
Drugs called artemisinins are safe and exhibit potent, rapid anti-malarial activity. In combination with other anti-malarials, they have been used effectively for several years to treat multiple-drug-resistant malaria. But resistance has arisen and will surely increase, so that in the absence of a vaccine, elimination of the mosquitoes that spread the disease is the key to preventing epidemics.
Unfortunately, flawed public policy limits the available options.
In 1972, on the basis of data on toxicity to fish and migrating birds (but not to humans), the US Environmental Protection Agency banned virtually all uses of DDT, an inexpensive and effective pesticide once widely deployed to kill disease-carrying insects. DDT was subsequently banned for agricultural use worldwide under the 2001 Stockholm Convention on Persistent Organic Pollutants, which stigmatized the chemical and effectively constituted a prohibition.
A basic principle of toxicology is that the dose makes the poison. Although DDT is a (modestly) toxic substance, there is a world of difference between applying large amounts of it in the environment — as farmers did before it was banned — and using it carefully and sparingly to fight mosquitoes and other disease-carrying insects. (When it is used now, if at all, it is sprayed indoors in small amounts to prevent mosquitoes from nesting).
The regulators who banned DDT also failed to take into consideration the inadequacy of alternatives. Because it persists after spraying, DDT works far better than many pesticides now in use, some of which are toxic to fish and other aquatic organisms. With DDT unavailable, many authorities attempting to control mosquitoes are depleting their budgets by repeated spraying with short-acting, marginally effective insecticides.
Moreover, even if mosquitoes become resistant to the killing effects of DDT, they are still repelled by it. An occasional dusting of window frames and door frames is extremely effective. Gates’s experts seem not to know this; the foundation’s annual letter contains the following single mention of DDT: “The world hoped in the 1950s and 1960s that [malaria] could be eliminated by killing mosquitoes with DDT, but that tactic failed when the mosquitoes evolved to be resistant to the chemical.”
Since DDT was banned, insect-borne diseases such as malaria and dengue have been on the rise. In fact, the huge toll of diseases spread by mosquitoes has led some public-health officials to rethink DDT’s use. In 2006, after roughly 50 million preventable deaths, the WHO reversed course and endorsed the use of DDT to kill and repel Anopheles mosquitoes.
Arata Kochi, the WHO official in charge of malaria said: “We must take a position based on the science and the data. One of the best tools we have against malaria is indoor residual spraying. Of the dozen or so insecticides WHO has approved as safe for house spraying, the most effective is DDT.”
However, policies based on science and data have a short half-life at the UN. With a notable absence of fanfare, in May last year the WHO, together with the UN Environment Program, reverted to endorsing less effective methods for preventing malaria, announcing that their goal is “to achieve a 30 percent cut in the application of DDT worldwide by 2014 and its total phase-out by the early 2020s, if not sooner.”
In the absence of effective vaccines or new anti-malarial drugs — and the funding and infrastructure to deliver them — this decision is tantamount to mass murder, a triumph of radical environmental politics over public health.
How can we drain the public-policy swamp?
First, governments should re-evaluate the voluminous data on DDT that have been compiled since the 1970’s and they should make DDT available immediately for mosquito control indoors.
Second, governments should oppose international restrictions on DDT and withhold all funding from UN agencies that oppose the use of the “best available technology” (including DDT) to control mosquito-borne diseases.
Third, public-health officials should embark on a campaign to educate local authorities and citizens about DDT. People now hear only the reflexively anti-pesticide drumbeat of the environmental movement, the lamentable legacy of the benighted Rachel Carson and her acolytes.
And oh, yes, it would be helpful if the world’s greatest philanthropist were to throw his weight behind removing the stigma on DDT.
Henry Miller, a physician and molecular biologist, is a fellow at Stanford University’s Hoover Institution. He was formerly at the US National Institutes of Health and Food and Drug Administration.
COPYRIGHT: PROJECT SYNDICATE
Taiwan should reject two flawed answers to the Eswatini controversy: that diplomatic allies no longer matter, or that they must be preserved at any cost. The sustainable answer is to maintain formal diplomatic relations while redesigning development relationships around transparency, local ownership and democratic accountability. President William Lai’s (賴清德) canceled trip to Eswatini has elicited two predictable reactions in Taiwan. One camp has argued that the episode proves Taiwan must double down on support for every remaining diplomatic ally, because Beijing is tightening the screws, and formal recognition is too scarce to risk. The other says the opposite: If maintaining
India’s semiconductor strategy is undergoing a quiet, but significant, recalibration. With the rollout of India Semiconductor Mission (ISM) 2.0, New Delhi is signaling a shift away from ambition-driven leaps toward a more grounded, capability-led approach rooted in industrial realities and institutional learning. Rather than attempting to enter the most advanced nodes immediately, India has chosen to prioritize mature technologies in the 28-nanometer to 65-nanometer range. That would not be a retreat, but a strategic alignment with domestic capabilities, market demand and global supply chain gaps. The shift carries the imprimatur of Indian Prime Minister Narendra Modi, indicating that the recalibration is
Chinese Nationalist Party (KMT) Chairwoman Cheng Li-wun (鄭麗文), during an interview for the podcast Lanshuan Time (蘭萱時間) released on Monday, said that a US professor had said that she deserved to be nominated for the Nobel Peace Prize following her meeting earlier this month with Chinese President Xi Jinping (習近平). Cheng’s “journey of peace” has garnered attention from overseas and from within Taiwan. The latest My Formosa poll, conducted last week after the Cheng-Xi meeting, shows that Cheng’s approval rating is 31.5 percent, up 7.6 percentage points compared with the month before. The same poll showed that 44.5 percent of respondents
China last week announced that it picked two Pakistani astronauts for its Tiangong space station mission, indicating the maturation of the two nations’ relationship from terrestrial infrastructure cooperation to extraterrestrial strategic domains. For Taiwan and India, the developments present an opportunity for democratic collaboration in space, particularly regarding dual-use technologies and the normative frameworks for outer space governance. Sino-Pakistani space cooperation dates back to the end of the Cold War in the 1990s, with a cooperative agreement between the Pakistani Space & Upper Atmosphere Research Commission, and the Chinese Ministry of Aerospace Industry. Space cooperation was integrated into the China-Pakistan